Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Aytu Biopharma (AYTU) Gross Profit (2016 - 2026)

Aytu Biopharma has reported Gross Profit over the past 12 years, most recently at $9.6 million for Q4 2025.

  • Quarterly Gross Profit fell 10.77% to $9.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $41.9 million through Dec 2025, down 5.24% year-over-year, with the annual reading at $45.8 million for FY2025, 6.57% down from the prior year.
  • Gross Profit was $9.6 million for Q4 2025 at Aytu Biopharma, up from $9.2 million in the prior quarter.
  • Over five years, Gross Profit peaked at $18.6 million in Q2 2023 and troughed at $9.2 million in Q3 2025.
  • The 5-year median for Gross Profit is $12.5 million (2021), against an average of $12.8 million.
  • Year-over-year, Gross Profit surged 44.77% in 2022 and then crashed 40.47% in 2024.
  • A 5-year view of Gross Profit shows it stood at $12.3 million in 2021, then surged by 40.6% to $17.3 million in 2022, then dropped by 15.56% to $14.6 million in 2023, then decreased by 26.14% to $10.8 million in 2024, then decreased by 10.77% to $9.6 million in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Gross Profit are $9.6 million (Q4 2025), $9.2 million (Q3 2025), and $10.3 million (Q2 2025).